iBio (IBIO) Invested Capital (2022 - 2025)
iBio (IBIO) posted quarterly Invested Capital of $16000.0 for Q3 2025, down 91.21% year-over-year from $182000.0 in Q3 2024, and down 75.0% quarter-over-quarter from $64000.0 in Q2 2025.
iBio (IBIO) Invested Capital (2022 - 2025) Analysis & Trends
iBio (IBIO) has reported Invested Capital for 4 consecutive years, with $16000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Invested Capital fell 91.21% year-over-year to $16000.0; the TTM figure through Mar 2026 stood at $80000.0 (down 87.2% YoY), while the FY2025 annual figure was $64000.0, down 64.04% from the prior year.
- Invested Capital retreated to $16000.0 in Q3 2025 per IBIO's latest filing, from $64000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $814000.0 in Q3 2022 and bottomed at $16000.0 in Q3 2025.
- Historically, Invested Capital has averaged $209875.0 across 4 years, with a median of $157500.0 in 2023.
- Annual changes were most pronounced in 2024 — Invested Capital gained 11.25% — and 2025, when it plunged 91.21%.
- iBio's Invested Capital stood at $814000.0 in 2022, then tumbled by 80.34% to $160000.0 in 2023, then slipped by 3.12% to $155000.0 in 2024, then slumped by 89.68% to $16000.0 in 2025.
- Business Quant data shows IBIO's Invested Capital at $16000.0 in Q3 2025, $64000.0 in Q2 2025, and $110000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 178,000.00 |
| Jun 30, 2023 | 160,000.00 |
| Sep 30, 2022 | 814,000.00 |